As presented in Fig. 1B, a total of 145 DEGs were found to be involved in both cancer progression and drug resistance; among them, MAGEA6 log2 FC was most significantly expressed in TCGA, and significant differences were also found in GSE26459/GSE16179 (suggesting involvement in drug resistance). The gene discussed is MAGEA6; the disease is cancer.